Tag Archives: BAYRY

best way to invest money

U.S. President Donald Trump’s new tariffs on imported steel and aluminum are creating tremendous profit opportunities in steel and aluminum stocks.

However, the best tariff stock to buy isn’t in the steel or aluminum industry – it’s a tech company positioned to revolutionize steel production and produce explosive profits while doing it.

You see, while tariffs may boost American steel production in the short term, both American and Chinese steel manufactures are turning to technology in an effort to lower costs, generate sustainable profits, and take advantage of a rapidly changing global economic landscape in the long term.

best way to invest money: Bayer Aktiengesellschaft (BAYRY)

Advisors’ Opinion:

  • [By ]

    Major competitive vendors that are developing treatments for pericarditis include:

    Pfizer Inc. (PFE) Abbvie, Inc. (ABBV) XBiotech Inc. (XBIT) Handok AstraZeneca (AZN) Bayer AG (OTCPK:BAYRY) Reckitt Benckiser Group plc. (RB) PerkinElmer, Inc. (PKI) FUJIFILM Holdings Corporation (OTCPK:FUJIY) Merck Sharp & Dohme Corp. (MRK) ALLERGAN (AGN)

    Concerning competitive advantage, management of the company is not aware of any therapies currently approved by the FDA for the treatment of recurrent pericarditis, the firms lead indication for rilonacept.

  • [By ]

    Bayer AG (BAYRY) also rose 4.13% to 97.29 on reports that its mega-merger with Monsanto Co. (MON) would likely be approved by the Department of Justice. The Wall Street Journal reported that the companies have agreed additional asset sales.

  • [By Todd Campbell]

    Based on the company’s results, Bayer AG (NASDAQOTH:BAYRY) licensed the rights to larotrectinib in a nine-figure deal that included $400 million up front andup to $450 million in regulatory and first-sale milestones. The two companies will split profit in the United States. Outside the U.S.,Loxo Oncology will get tiered double-digit royalties based on sales levels, as well as up to $475 million in sales-based milestones.

  • [By ]

    And why did Bayer (OTCPK:BAYRY) buy this drug, too?

    Unfortunately, in most cases, resistance is inevitable at some point, even if you attain a strong response that lasts a while. It is a near-truism that patients will eventually acquire resistance to kinase inhibitors, except in rare exceptional circumstances and treatment settings like chronic myeloid leukemia, where a lot of patients can have a persistent remission for years and years.

best way to invest money: Zillow Group, Inc.(Z)

Advisors’ Opinion:

  • [By Rich Duprey, Nicholas Rossolillo, and Maxx Chatsko]

    But just as the market itself is a forward-looking machine, we asked three investors to pick one stock they believe could put NVIDIA’s returns to shame in the future. They chose Atlassian (NASDAQ:TEAM), Appian (NASDAQ:APPN), and Zillow (NASDAQ:Z).

  • [By Motley Fool Staff]

    Zillow Group (C shares) (NASDAQ:Z) Q1 2018 Earnings Conference CallMay. 7, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Anders Bylund]

    Shares of Zillow Group (NASDAQ:Z) (NASDAQ:ZG) fell hard on Friday morning. Class A shares fell as much as 11.1% and the non-voting Class C stock dropped 10.4% lower at most. As of 3 p.m. EDT, both stock classes had recovered somewhat to a daily loss of approximately 7.5%.

best way to invest money: Grupo Supervielle S.A. (SUPV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Mckinley Capital Management LLC Delaware lowered its holdings in Grupo Supervielle (NYSE:SUPV) by 19.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 33,744 shares of the company’s stock after selling 7,984 shares during the quarter. Mckinley Capital Management LLC Delaware’s holdings in Grupo Supervielle were worth $1,023,000 as of its most recent SEC filing.

best way to invest money: Centennial Resource Development, Inc. (CDEV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Centennial Resource Dev (CDEV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Amedica Corporation (NASDAQ: AMDA) rose 31.3 percent to $4.11 in pre-market trading after climbing 181.98 percent on Tuesday.
    ZAGG Inc (NASDAQ: ZAGG) rose 18.7 percent to $13.65 in pre-market trading after the company posted better-than-expected Q1 earnings.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 18.6 percent to $46.00 in pre-market trading after the company reported stronger-than-expected results for its first quarter on Tuesday.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 15 percent to $2.08 in pre-market trading after reporting Q4 results.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 9.8 percent to $49.00 in pre-market trading following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Centennial Resource Development, Inc. (NASDAQ: CDEV) shares rose 8.1 percent to $21.06 in pre-market trading following Q1 results.
    OPKO Health, Inc. (NASDAQ: OPK) shares rose 6.8 percent to $3.44 in pre-market trading following Q1 beat.
    Tel-Instrument Electronics Corp. (NYSE: TIK) rose 6.7 percent to $3.20 in pre-market trading after surging 25.37 percent on Tuesday.
    KBS Fashion Group Limited (NASDAQ: KBSF) rose 6.4 percent to $5.84 in pre-market trading after jumping 9.36 percent on Tuesday.
    Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) rose 6.6 percent to $8.26 in pre-market trading after reporting Q2 earnings.
    New Relic, Inc. (NYSE: NEWR) rose 6.3 percent to $82.00 in pre-market trading following Q4 results.
    Match Group, Inc. (NASDAQ: MTCH) rose 5.8 percent to $38.43 in pre-market trading after reporting upbeat Q1 earnings.
    Prestige Brands Holdings, Inc. (NYSE: PBH) rose 5.2 percent to $30.62 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers
    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares jumped 31.6 percent to $12.18 following TripAdvisor Q1 earnings beat.
    ZAGG Inc (NASDAQ: ZAGG) rose 26.5 percent to $14.55 after the company posted better-than-expected Q1 earnings.
    OPKO Health, Inc. (NASDAQ: OPK) shares gained 25 percent to $4.0234 following Q1 beat.
    Axon Enterprise, Inc. (NASDAQ: AAXN) jumped 23.5 percent to $55.12 following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Penn Virginia Corporation (NASDAQ: PVAC) gained 23.3 percent to $59.00 after reporting Q1 results.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 22.5 percent to $47.51 after the company reported stronger-than-expected results for its first quarter on Tuesday.
    Sears Holdings Corporation (NASDAQ: SHLD) shares surged 21.7 percent to $3.36. Amazon.com's partnership with Sears started in 2017 with an agreement to sell Kenmore-branded appliances online. On Wednesday, the companies announced an extension of their relationship to now include tire delivery and installations.
    EP Energy Corporation (NYSE: EPE) jumped 21.3 percent to $2.68 following Q1 results.
    LendingClub Corporation (NYSE: LC) surged 20.4 percent to $3.395 following better-than-expected Q1 earnings.
    Superior Industries International, Inc. (NYSE: SUP) gained 19 percent to $15.82 after reporting Q1 results.
    Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) shares rose 18.5 percent to $8.13 following Q1 results.
    Twilio Inc. (NYSE: TWLO) rose 18.3 percent to $52.47 after the company posted strong quarterly results.
    Cerus Corporation (NASDAQ: CERS) shares jumped 18.3 percent to $6.47 following quarterly results.
    IEC Electronics Corp. (NYSE: IEC) shares climbed 17 percent to $4.68 after reporting better-than-expected quarterly earnings.
    New Relic, Inc. (NYSE: NEWR) rose 16.8 percent to $90.10 following Q4 results.
    Gulfport Energy Corporation (NASDAQ: GPOR)

Top 10 Heal Care Stocks To Buy For 2018

Introduction

Apple’s (AAPL) Services division is now the second-largest business segment in the company’s arsenal. A big driver of this growth has been Apple Music. However, nearly one and a half years later, the question still remains, “What impact is Apple Music going to have?”

Over the past year, the company has seen its iPhone, Mac and “Other Products” segments drop by double digits in revenue. During the same time frame, Apple Music has grown 22% in revenue alongside Apple Services 24% growth. It has been a small saving grace for investors during the most recent earnings release.

How much does it cost to service each subscriber?

Royalties

According to the New York Times, Apple pays $0.002 per stream in royalty fees. Additionally, music publishers earn $0.47 per 1000 streams. This totals $2.47 per 1,000 streams, which can be treated as its cost of goods sold.

In 2013, Spotify’s (Private:MUSIC) users listened to approximately 110 minutes of streamed music per day. Assuming the average song length is three minutes, there would be 1,100 songs listened to per month. That would be the equivalent of $2.72 worth of Apple Music payments.

Top 10 Heal Care Stocks To Buy For 2018: Petroquest Energy Inc(PQ)

Advisors’ Opinion:

  • [By Ethan Ryder]

    News headlines about Petroquest Energy (NYSE:PQ) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Petroquest Energy earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave news stories about the energy company an impact score of 47.638327846877 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Top 10 Heal Care Stocks To Buy For 2018: Bayer Aktiengesellschaft (BAYRY)

Advisors’ Opinion:

  • [By ]

    Both companies reported that the phase 3 trial known as IMblaze370 had failed. This study recruited a total of 363 patients with locally advanced or metastatic colorectal cancer. One key thing to note first is that the patients that were recruited into the study, were those who had already been heavily pretreated with 2 or more prior regimens of chemotherapy. The trial was putting the combination of Tecentriq and Cotellic versus the control arm which was regorafenib (STIVARGA) from Bayer (OTCPK:BAYRY). Unfortunately, the treatment combination arm failed to improve overall survival versus the control arm. There was no actual results released yet. It was stated that full detailed results from this study will be released at an upcoming medical conference. The problem is that it doesn’t matter what the results are, the bottom-line is that the primary endpoint was not met.

  • [By Cory Renauer]

    It looks like the benefit-to-risk ratio is off the charts for larotrectinib as well as LOXO-292, but the number of patients with TRK fusion cancers that fail multiple existing treatments is somewhere between 1,500 and 5,000 each year in the U.S. Investors also need to understand that Loxo Oncology licensed its candidates from Array Biopharma (NASDAQ:ARRY) and owes its partner substantial milestone payments and mid-single-digit royalties on any sales they might generate. Loxo has partnered withBayer AG (NASDAQOTH:BAYRY), and if approved, the German giant will share U.S. profits with Loxo and pay double-digit royalties on sales abroad.

  • [By ]

    And why did Bayer (OTCPK:BAYRY) buy this drug, too?

    Unfortunately, in most cases, resistance is inevitable at some point, even if you attain a strong response that lasts a while. It is a near-truism that patients will eventually acquire resistance to kinase inhibitors, except in rare exceptional circumstances and treatment settings like chronic myeloid leukemia, where a lot of patients can have a persistent remission for years and years.

Top 10 Heal Care Stocks To Buy For 2018: NCI Building Systems, Inc.(NCS)

Advisors’ Opinion:

  • [By Max Byerly]

    Several equities research analysts have issued reports on the stock. ValuEngine cut shares of NCI Building Systems from a “buy” rating to a “hold” rating in a research note on Thursday. Stephens reaffirmed a “hold” rating and set a $20.00 price target on shares of NCI Building Systems in a research note on Thursday, March 15th. Barclays reaffirmed an “overweight” rating on shares of NCI Building Systems in a research note on Thursday, March 8th. Royal Bank of Canada reaffirmed a “buy” rating and set a $20.00 price target on shares of NCI Building Systems in a research note on Thursday, March 8th. Finally, Zacks Investment Research cut shares of NCI Building Systems from a “buy” rating to a “hold” rating in a research note on Wednesday, February 7th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $20.00.

    COPYRIGHT VIOLATION WARNING: “NCI Building Systems (NCS) Receiving Favorable Press Coverage, Report Finds” was originally posted by Ticker Report and is owned by of Ticker Report. If you are reading this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright & trademark law. The original version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3361896/nci-building-systems-ncs-receiving-favorable-press-coverage-report-finds.html.

    NCI Building Systems Company Profile

  • [By Stephan Byrd]

    NCI Building Systems (NYSE:NCS) was the target of a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 800,076 shares, a growth of 50.7% from the April 13th total of 531,044 shares. Currently, 1.9% of the company’s shares are short sold. Based on an average daily trading volume, of 323,193 shares, the short-interest ratio is presently 2.5 days.

Top 10 Heal Care Stocks To Buy For 2018: Regency Centers Corporation(REG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Regency Centers (REG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Fort Washington Investment Advisors Inc. OH purchased a new position in Regency Centers Co. (NYSE:REG) during the first quarter, HoldingsChannel.com reports. The firm purchased 8,200 shares of the real estate investment trust’s stock, valued at approximately $484,000.

Top 10 Heal Care Stocks To Buy For 2018: Fiat Chrysler Automobiles N.V.(FCAU)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Several car companies have made police versions of their vehicles over the years. Among the things the upgraded vehicles have is fast engines. Fiat Chrysler Automobiles N.V.’s (NYSE: FCAU) Dodge division has taken a vehicle that is already fast and modified it for law enforcement.

  • [By Zacks]

    The announcement should give a major boost to the confidence of U.S. carmakers like Tesla, Inc. (NASDAQ: TSLA), General Motors Company (NYSE: GM), Fiat Chrysler Automobiles N.V. (NYSE: FCAU) and Ford Motor Company (NYSE: F) as full ownership will help them have complete control of their operations and allow no sharing of profits.

  • [By Douglas A. McIntyre]

    For some inexplicable reason, Fiat Chrysler Automobiles Inc.’s (NYSE: FCAU) Dodge division decided to sell its Ram pickup by using a speech by Dr. Martin Luther King Jr. The speech that the Fiat Chryslerad featured was given 50 years ago.

Top 10 Heal Care Stocks To Buy For 2018: Teladoc, Inc.(TDOC)

Advisors’ Opinion:

  • [By Simon Erickson]

    Teladoc’s (NYSE:TDOC) first-quarter results kicked off a good start to 2018. Their now fully integrated acquisition of Best Doctors helped revenue more than double for the second straight quarter and U.S. membership reach more than 20 million people.

  • [By Shane Hupp]

    Teladoc (NYSE:TDOC) CEO Jason N. Gorevic sold 25,000 shares of the business’s stock in a transaction dated Tuesday, May 15th. The shares were sold at an average price of $48.93, for a total transaction of $1,223,250.00. Following the transaction, the chief executive officer now directly owns 636,184 shares in the company, valued at approximately $31,128,483.12. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

  • [By Chris Hill]

    In today’s episode of MarketFoolery, host Chris Hill and Motley Fool analyst Jason Moser go through some of the messy metrics from this quarter and explain which areas long-term investors should focus on to track how the company is doing. Also, Texas Roadhouse(NASDAQ:TXRH) clocked in another good quarter, but how can the restaurant grow from here? Virtual healthcare provider Teladoc (NYSE:TDOC)reports earnings later today, and long-term investors should watch for progress in these key metrics. Tune in to find out more.

  • [By Rich Duprey, Nicholas Rossolillo, and Maxx Chatsko]

    We posed that question to a team of Motley Fool investors to identify three stocks our kids will brag about having owned for years, and they picked U.S. Concrete (NASDAQ:USCR), Teladoc (NYSE:TDOC), and Rollins (NYSE:ROL). Read on to find out why these companies deserve that distinction.

Top 10 Heal Care Stocks To Buy For 2018: Hertz Global Holdings Inc(HTZ)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Hertz Global Holdings, Inc. (NYSE: HTZ) were down 17 percent to $18.505 after the company reported a wider-than-expected loss for its first quarter.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Nevro Corp. (NASDAQ: NVRO) fell 11.6 percent to $81.58 in pre-market trading after reporting wider-than-expected Q1 loss.
    Hertz Global Holdings, Inc. (NYSE: HTZ) shares fell 8.3 percent to $20.33 in pre-market trading after the company reported a wider-than-expected loss for its first quarter.
    Zillow Group, Inc. (NASDAQ: Z) fell 7.5 percent to $51.74 in pre-market trading. Zillow reported upbeat earnings for its first quarter, but issued weak sales guidance for the second quarter.
    Sanchez Energy Corporation (NYSE: SN) fell 7.2 percent to $3.11 in pre-market trading after reporting wider-than-expected Q1 loss.
    Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 5.5 percent to $4.14 in pre-market trading after rising 11.17 percent on Monday.
    Albemarle Corporation (NYSE: ALB) fell 5.1 percent to $95.00 in pre-market trading. Albemarle declared a quarterly dividend of $0.335 per share.
    Tata Motors Limited (NYSE: TTM) fell 4.8 percent to $23.80 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) fell 4.5 percent to $57.14 in pre-market trading after reporting Q1 results.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares fell 4.3 percent to $2.25 in pre-market trading after gaining 1.73 percent on Monday.
    51job, Inc. (NASDAQ: JOBS) shares fell 4.2 percent to $93 in pre-market trading after rising 3.55 percent on Monday

  • [By Max Byerly]

    These are some of the news articles that may have impacted Accern’s rankings:

    Get Hertz Global alerts:

    Hertz Global Holdings, Inc (HTZ) CFO Thomas C. Kennedy Buys 15,000 Shares (americanbankingnews.com) Northcoast Research Weighs in on Hertz Global Holdings, Inc’s Q2 2018 Earnings (HTZ) (americanbankingnews.com) Hertz Global Target of Unusually High Options Trading (HTZ) (americanbankingnews.com) Edited Transcript of HTZ earnings conference call or presentation 8-May-18 12:00pm GMT (finance.yahoo.com) Hertz Sweeps 2018 FlyerTalk Awards (finance.yahoo.com)

    Several equities research analysts have issued reports on HTZ shares. Zacks Investment Research upgraded Hertz Global from a “sell” rating to a “hold” rating in a research report on Wednesday, January 17th. Macquarie upgraded Hertz Global from a “neutral” rating to an “outperform” rating in a research report on Thursday, January 18th. Goldman Sachs dropped their target price on Hertz Global from $15.00 to $13.00 and set a “sell” rating on the stock in a research report on Thursday, February 15th. Finally, ValuEngine downgraded Hertz Global from a “hold” rating to a “sell” rating in a research report on Thursday, February 15th. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $15.71.

  • [By Dan Caplinger]

    The stock market dealt with continued volatility on Tuesday, with investors uncertain how to react to a mix of earnings and geopolitical news. Throughout most of the day, market participants were trying to predict whether the Trump administration would move forward with its plans to withdraw the U.S. from the nuclear deal with Iran, and major benchmarks stayed in a relatively tight range with a downward bias during the morning and early afternoon. After the expected announcement, the Dow fell to a triple-digit loss late in the afternoon, but it recovered by the end of the session. Adding to the gloominess was bad news regarding some key individual stocks. DISH Network (NASDAQ:DISH), Gogo (NASDAQ:GOGO), and Hertz Global Holdings (NYSE:HTZ) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Garrett Baldwin]

    Oil prices are at levels we haven’t seen in years. U.S. crude topped $70 for the first since 2014, as U.S. President Donald Trump appeared increasingly likely to pull out of the Iran nuclear deal and reinforce sanctions on Tehran. In addition, OPEC has announced plans to bolster prices and cap production. For oil investors, Money MorningGlobal Energy Strategist Dr. Kent Moors says it’s time to buckle up. According to Moors, revoking the Iran deal would cause “price chaos” around the globe. And that’s right as driving season starts in the United States. Here’s more on the coming chaos for oil. In deal news, Blackstone Group (NYSE: BX) announced it will purchase Gramercy Property Trust (NYSE: GPT) for $7.6 billion in cash. Grammercy manages commercial real estate. While this may seem like a boring deal, Blackstone is buying a business that churns out cold hard cash for its investors. We want to keep this deal on your radar, because there are many other deals like this coming down the pipeline. We’re going to be discussing one of the best real estate opportunities available very soon – so keep an eye out for updates.
    Three Stocks to Watch Today: AMZN, AAPL, TSN, SBUX
    Shareholders of Amazon.com Inc. (Nasdaq: AMZN) cheered statements made by Warren Buffett over the weekend. The Oracle of Omaha said he messed up by not investing in Amazon and Alphabet Inc. (Nasdaq: GOOGL). “I made the wrong decisions on Google and Amazon,” Buffett said on Saturday. “We’ve looked at it. I made the mistake in not being able to come to a conclusion where I really felt that at the present prices that the prospects were far better than the prices indicated.” Buffett says he now has a “very, very, very high opinion” of Amazon CEO Jeff Bezos. The Oracle believes that Bezos has created something that is “close to a miracle.” Apple Inc. (Nasdaq: AAPL) added another 0.6% Monday, to reach $185.00 per share – a new 52-week high. The uptick came after Warren Buffett announced

  • [By Lisa Levin]

    Shares of Hertz Global Holdings, Inc. (NYSE: HTZ) were down 11 percent to $19.77 after the company reported a wider-than-expected loss for its first quarter.

Top 10 Heal Care Stocks To Buy For 2018: Tile Shop Hldgs, Inc.(TTS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Tile Shop Holdings, Inc. (NASDAQ: TTS) got a boost, shooting up 9 percent to $6.20 after the company posted upbeat quarterly earnings.

    Sientra, Inc. (NASDAQ: SIEN) shares were also up, gaining 9 percent to $12.03 following the announcement of FDA approval for PMA supplement.

  • [By Jason Hall]

    On the surface, there doesn’t seem to be much good inTile Shop Holdings Inc’s(NASDAQ:TTS) first-quarter earnings report. Sales fell 1% on a big 6.8% decline in comparable-store sales, earnings per share fell 47%, and expenses increased at double-digit rate. Surprisingly, Tile Shop’s shares traded up as much as 7% and finished the day of its earnings release up 5%.

  • [By Paul Ausick]

    Tile Shop Holdings Inc. (NASDAQ: TTS) dropped more than 31% Wednesday to post a new 52-week low of $5.80. Shares closed at $8.45 on Tuesday and the stock’s 52-week high is $22.40. Volume was around 6.3 million, about eight times the daily average of about 780,000. The company reported a quarterly loss this morning.

Top 10 Heal Care Stocks To Buy For 2018: The ExOne Company(XONE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Ex One (NASDAQ: XONE) and Voxeljet (NYSE:VJET) are both small-cap industrial products companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership.

  • [By Paul Ausick]

    Short interest in The ExOne Co. (NASDAQ: XONE) fell by 1.7% to 1.86 million shares. About 19.8% of the company’s shares were short. ExOne’s share price jumped by about 14.2% in the period. The stock’s 52-week range is $6.72 to $14.43, and shares closed at $10.39 on Wednesday, up about 1.6% for the day. Days to cover rose from eight to 11.

  • [By Paul Ausick]

    Short interest in The ExOne Co. (NASDAQ: XONE) rose by 4.9% to 2.38 million shares. About 24.4% of the company’s shares were short. ExOne’s share price fell by about 3.4% in the period ending April 30. The stock’s 52-week range is $6.72 to $14.43, and shares closed at $7.19 on Wednesday, up about 2.7% for the day. Days to cover rose from 22 to 23.

Top 10 Heal Care Stocks To Buy For 2018: CB Financial Services, Inc.(CBFV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    CB Financial Services Inc (NASDAQ:CBFV)’s share price hit a new 52-week high and low on Wednesday following a dividend announcement from the company. The company traded as low as $34.95 and last traded at $34.40, with a volume of 4600 shares traded. The stock had previously closed at $34.65.

Top 5 Casino Stocks To Buy For 2019

Stars Group Inc.’s $4.7-billion purchase of Sky Betting & Gaming turns the online poker giant into a major sports-betting player that could use its strong foothold in Europe to cross the Atlantic if the U.S. market fully opens.

The Toronto-based operator of PokerStars, which announced the cash-and-stock deal with CVC Capital Partners and Sky Plc on Saturday, is set to win a significant foothold in the U.K. — the largest regulated gaming market. Sky Betting & Gaming, or SBG, is growing rapidly in online casino games and sports at home and recently expanded to Italy and Germany.

If an upcoming Supreme Court decision in the U.S. allows sports betting in more states, it would be the “icing on the cake” for the combined companies, according to Simon Holliday, founder of the research firm H2 Gambling Capital.

“The US sportsbetting Supreme Court case is obviously a big part of the potential upside, with Star’s old database, SBG’s strengths and their track record solely in the U.K.,” Holliday wrote in an email. “Even without the U.S., SBG is just starting to launch in other regulated markets.”

Top 5 Casino Stocks To Buy For 2019: Northwest Natural Gas Company(NWN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    NW Natural (NYSE:NWN) was downgraded by equities research analysts at ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday.

Top 5 Casino Stocks To Buy For 2019: Escalade, Incorporated(ESCA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Escalade (NASDAQ: ESCA) and Sports Direct Intl (OTCMKTS:SDISY) are both consumer discretionary companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, earnings, analyst recommendations, risk and valuation.

Top 5 Casino Stocks To Buy For 2019: Mosaic Company (MOS)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Oil prices are at levels we haven’t seen in years. U.S. crude topped $70 for the first since 2014, as U.S. President Donald Trump appeared increasingly likely to pull out of the Iran nuclear deal and reinforce sanctions on Tehran. In addition, OPEC has announced plans to bolster prices and cap production. For oil investors, Money MorningGlobal Energy Strategist Dr. Kent Moors says it’s time to buckle up. According to Moors, revoking the Iran deal would cause “price chaos” around the globe. And that’s right as driving season starts in the United States. Here’s more on the coming chaos for oil. In deal news, Blackstone Group (NYSE: BX) announced it will purchase Gramercy Property Trust (NYSE: GPT) for $7.6 billion in cash. Grammercy manages commercial real estate. While this may seem like a boring deal, Blackstone is buying a business that churns out cold hard cash for its investors. We want to keep this deal on your radar, because there are many other deals like this coming down the pipeline. We’re going to be discussing one of the best real estate opportunities available very soon – so keep an eye out for updates.
    Three Stocks to Watch Today: AMZN, AAPL, TSN, SBUX
    Shareholders of Amazon.com Inc. (Nasdaq: AMZN) cheered statements made by Warren Buffett over the weekend. The Oracle of Omaha said he messed up by not investing in Amazon and Alphabet Inc. (Nasdaq: GOOGL). “I made the wrong decisions on Google and Amazon,” Buffett said on Saturday. “We’ve looked at it. I made the mistake in not being able to come to a conclusion where I really felt that at the present prices that the prospects were far better than the prices indicated.” Buffett says he now has a “very, very, very high opinion” of Amazon CEO Jeff Bezos. The Oracle believes that Bezos has created something that is “close to a miracle.” Apple Inc. (Nasdaq: AAPL) added another 0.6% Monday, to reach $185.00 per share – a new 52-week high. The uptick came after Warren Buffett announced

  • [By ]

    HSBC’s top stocks list is mostly dominated by large-cap plays that happen to pay attractive dividend yields. More importantly, the stocks already have a decent amount of momentum behind them: the average one-month performance is +5.5%. 

    Baker Hughes (BHGE) Tiffany & Co. (TIF) The Mosaic Company (MOS) Deutsche Telekom Schneider Electric Adidas (ADDYY) Unicredit  CRH (CRH) Luftansa  GlaxosmithKline (GSK) Associated British Foods   Fresnillo China Construction Bank China Overseas Land & Inv. Geely Automobile Holdings CRCC China Resources Beer Samsung Electronic Sasol Adani Ports and SEZ

  • [By Stephan Byrd]

    The Mosaic Company (NYSE:MOS) has been assigned an average rating of “Hold” from the nineteen brokerages that are covering the company, MarketBeat reports. Four equities research analysts have rated the stock with a sell recommendation, ten have given a hold recommendation and five have given a buy recommendation to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $25.23.

  • [By Joseph Griffin]

    The Mosaic (NYSE:MOS) issued its quarterly earnings data on Monday. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.28 by ($0.08), Bloomberg Earnings reports. The Mosaic had a negative net margin of 1.45% and a positive return on equity of 3.90%. The firm had revenue of $1.93 billion during the quarter, compared to analyst estimates of $1.85 billion. During the same period last year, the business earned $0.04 EPS. The firm’s revenue was up 22.5% compared to the same quarter last year. The Mosaic updated its FY18 guidance to $1.20-1.60 EPS.

Top 5 Casino Stocks To Buy For 2019: Bayer Aktiengesellschaft (BAYRY)

Advisors’ Opinion:

  • [By ]

    Major competitive vendors that are developing treatments for pericarditis include:

    Pfizer Inc. (PFE) Abbvie, Inc. (ABBV) XBiotech Inc. (XBIT) Handok AstraZeneca (AZN) Bayer AG (OTCPK:BAYRY) Reckitt Benckiser Group plc. (RB) PerkinElmer, Inc. (PKI) FUJIFILM Holdings Corporation (OTCPK:FUJIY) Merck Sharp & Dohme Corp. (MRK) ALLERGAN (AGN)

    Concerning competitive advantage, management of the company is not aware of any therapies currently approved by the FDA for the treatment of recurrent pericarditis, the firms lead indication for rilonacept.

  • [By ]

    Both companies reported that the phase 3 trial known as IMblaze370 had failed. This study recruited a total of 363 patients with locally advanced or metastatic colorectal cancer. One key thing to note first is that the patients that were recruited into the study, were those who had already been heavily pretreated with 2 or more prior regimens of chemotherapy. The trial was putting the combination of Tecentriq and Cotellic versus the control arm which was regorafenib (STIVARGA) from Bayer (OTCPK:BAYRY). Unfortunately, the treatment combination arm failed to improve overall survival versus the control arm. There was no actual results released yet. It was stated that full detailed results from this study will be released at an upcoming medical conference. The problem is that it doesn’t matter what the results are, the bottom-line is that the primary endpoint was not met.

  • [By ]

    Bayer AG (BAYRY) also rose 4.13% to 97.29 on reports that its mega-merger with Monsanto Co. (MON) would likely be approved by the Department of Justice. The Wall Street Journal reported that the companies have agreed additional asset sales.

  • [By ]

    And why did Bayer (OTCPK:BAYRY) buy this drug, too?

    Unfortunately, in most cases, resistance is inevitable at some point, even if you attain a strong response that lasts a while. It is a near-truism that patients will eventually acquire resistance to kinase inhibitors, except in rare exceptional circumstances and treatment settings like chronic myeloid leukemia, where a lot of patients can have a persistent remission for years and years.

Top 5 Casino Stocks To Buy For 2019: NV5 Global, Inc.(NVEE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on NV5 Global (NVEE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jason Hall]

    NV5’s (NASDAQ:NVEE) stock has been up and down and all around since being recommended, but the company still looks to be in a fantastic long-term position. Pattern Energy’s (NASDAQ:PEGI) stock has been a bit worse for wear, as the tax code has presented some new and significant challenges. But Pattern’s story doesn’t end there, and there’s plenty of bright spots for the business. Tune in to find out how rec-worthy these companies are today and what investors need to know about them before buying.

  • [By Logan Wallace]

    NV5 Global (NASDAQ:NVEE) VP Richard Tong sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, May 7th. The shares were sold at an average price of $66.40, for a total transaction of $66,400.00. Following the completion of the transaction, the vice president now owns 34,933 shares of the company’s stock, valued at $2,319,551.20. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Top 5 Warren Buffett Stocks To Buy Right Now

Michael A. Robinson

“Look at market fluctuations as your friend rather than your enemy; profit from folly rather than participate in it.”

– Warren Buffett

It’s tough to argue with the”Oracle of Omaha.”

AndWarren Buffettis right: Investor “folly” creates some of the biggest money-making opportunities you’ll find in stocks.

Just look at the go-nowhere market we’ve been seeing in recent weeks. Stocks may plummet one day only to soar the next – all because of the bearish or bullish economic statisticdu jour– but they’ve stayed in a very tight range for close to eight weeks.

When we reach the end of this year, I believe that the tech investors who stayed in the market – and selected the best stocks, with my help – will see that they’ve been rewarded for their courage. Those who spent 2016 on the sidelines will be penalized for their caution.

Top 5 Warren Buffett Stocks To Buy Right Now: Genesis Energy, L.P.(GEL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Breaking news

    Lennar Corporation (NYSE: LEN) reported better-than-expected profit for its first quarter on Tuesday.
    General Mills, Inc. (NYSE: GIS) reported upbeat earnings for its fiscal third quarter, while sales missed estimates.
    Genesis Energy, L.P. (NYSE: GEL) disclosed that it has priced its public offering of 4 million common units for gross proceeds of $124 million.
    South State Corporation (NASDAQ: SSB) reported that it has increased its buyback plan from 250,000 shares to 1 million shares.

  • [By ]

    Genesis Energy LP (NYSE: GEL)
    Billing itself as a “growth-oriented master limited partnership,” GEL concentrates its efforts on providing services around and within refineries primarily located on the Gulf Coast. Management is committed to logical double-digit growth as well as strengthening its distribution coverage. At $20.80 per unit, GEL yields 11.8% and trades at a nearly 40% discount to its 52-week high.

Top 5 Warren Buffett Stocks To Buy Right Now: Rice Midstream Partners LP(RMP)

Advisors’ Opinion:

  • [By Paul Ausick]

    Rice Midstream Partners LP (NYSE: RMP) posted a new 52-week low of $16.87 on Monday, down about 31% compared with Friday’s closing price of $24.36. Volume totaled around 8.3 million shares, nearly 25 times the daily average of around 840,000. The company and its sponsor, Rice Energy, were acquired by EQT Corp.

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Petroleo Brasileiro S.A.- Petrobras (NYSE: PBR): Free Stock Analysis Report
     
    Bill Barrett Corporation (NYSE: BBG): Free Stock Analysis Report
     
    Northern Oil and Gas, Inc. (AMEX:NOG): Free Stock Analysis Report
     
    Rice Midstream Partners LP (NYSE: RMP): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research

Top 5 Warren Buffett Stocks To Buy Right Now: Bayer Aktiengesellschaft (BAYRY)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    BeforeBayer(NASDAQOTH: BAYRY)arrived onto the scene, I viewedMonsanto(NYSE: MON)as an intriguing growth stock. It has a rich history of delivering value to shareholders and continues to hold a dominant technological edge over key competitors in crop protection products, seeds, and traits. While little has changed its promising pipeline and portfolio, the pending acquisition throws a wrench in anyone’s plans to start or add to a position. Uncertainty stemming from the merger provides several terrible reasons to buy Monsanto at this time.

  • [By SEEKINGALPHA.COM]

    Fertilizers are only one input when it comes to farming, the equipment business has suffered, and seed suppliers are certainly concerned. Perhaps that is why another merger occurred last week between Monsanto (NYSE:MON) and Bayer (OTCPK:BAYRY). Bayer AG agreed to buy the U.S. seed manufacturer for $128 per share or approximately $47 billion creating a mammoth company with a combined value of almost $134.5 billion. The $128 per share price works out to a valuation of around 16 times earnings, which is cheap in a market where the average of S&P 500 stocks is trading at over 26.5 times earnings. However, the weakness in the agricultural sector caused disappointing earnings for Monsanto in the third quarter and a downbeat outlook for the future caused MON to accept Bayer’s bid. Bayer bought Monsanto at a low price, lowering the risk of the transaction for the German health care and agricultural giant.

  • [By SEEKINGALPHA.COM]

    This type of spin-off is not uncommon among German companies, as they streamline their portfolios to focus on the where they have more competitive advantages in the long term. For instance, in the recent past, Siemens (OTCPK:SIEGY) has split out Osram (OTC:OSAGY) and Bayer (OTCPK:BAYRY) has performed the spin-off of Covestro (OTCPK:CVXTY), something that Rheinmetall is likely to do in the near future because its auto unit has reached peak margins, and therefore this is the best time to spin-off the business.

  • [By SEEKINGALPHA.COM]

    You can torture the data many ways, of course, and there were some pharma price increases in the US, but apparently, they were not especially large. What hurt were discounting, especially for Xarelto, a Bayer (OTCPK:BAYRY) oral anticoagulant which JNJ markets in the US; and the diabetes Invokana line.

Top 5 Warren Buffett Stocks To Buy Right Now: Nomura Holdings Inc ADR(NMR)

Advisors’ Opinion:

  • [By Maureen Farrell]

    Shortly after Lehman declared bankruptcy, Barclays (BCS) paid $1.3 billion for most of the firm’s North American operations, its Times Square headquarters, and about 9,000 employees. Nomura Holdings (NMR) paid roughly $200 million for Lehman’s operations in Asia.

  • [By Money Morning News Team]

    Nomura Holdings Inc. (NYSE: NMR) is a Japanese financial services company that provides a variety of financial services to corporations, governments, institutions, and individuals around the world.

Top 5 Warren Buffett Stocks To Buy Right Now: The Herzfeld Caribbean Basin Fund, Inc.(CUBA)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    This "Trump pick" is a snub to the President’s trade and diplomatic reversals of Obama’s wins regarding Cuba. We are buying back Herzfeld Caribbean Basin Fund (CUBA), following in the footsteps of its founder, Tom Herzfeld, and his son Erik.

Top 5 Blue Chip Stocks To Buy Right Now

Investors can add all sorts of investments to an IRA, but many financial advisors will suggest sticking with conservative dividend stocks. The reason is simple — blue chip income generators generally bounce back from big market crashes, and the compounding effect of reinvested dividends can deliver massive returns over several decades.

At first glance, tobacco giant Altria (NYSE:MO) seems like a great stock for an IRA. Its flagship Marlboro brand dominates the U.S. market, it pays a hefty forward dividend yield of 3.4%, and it’s hiked that dividend every year since it spun off itsoverseas business as Philip Morris International (NYSE:PM) in 2008. But if you gaze further into Altria’s future, you’ll realize that it’s not a great long-term pick for your IRA at all.

Image source: Getty Images.

Why Altria seems like a good IRA stock

Altria shares have rallied 20% over the past 12 months, outperforming Philip Morris’ 15% rally but slightly underperforming the S&P 500’s 25% gain. Much of that growth can be attributed to two factors — a flight to high-yielding dividend stocks in a low interest rate environment and Altria’s purely domestic business insulating it from the currency headwinds which gobbled up Philip Morris’ overseas gains.

Top 5 Blue Chip Stocks To Buy Right Now: Apache Corporation(APA)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Apache Corp. (NYSE: APA), Halliburton Co. (NYSE: HAL), Revlon Inc. (NYSE: REV), Valeant Pharmaceuticals International Inc. (NYSE: VRX) and U.S. Steel Corp. (NYSE: X).

  • [By WWW.THESTREET.COM]

    Cramer and the Action Alerts PLUS team say they still believe in their embattled Permian names, Cimarex (XEC) and Apache (APA) , both of which have benefited from a slow rotation in recent weeks. These names can produce and profit here. Schlumberger (SLB) remains best in class and Magellan Midstream Partners just might be the best way to play oil given that the pipelines will be needed to transport the new wave of oil able to be drawn out of the ground from increasingly efficient American producers. Get in on the discussion by getting a free trial subscription to Action Alerts PLUS.

  • [By WWW.THESTREET.COM]

    Cramer and the AAP team are detailing their outlook for portfolio energy names Apache (APA) and Cimarex (XEC) . Find out what they’re telling their investment club members with a free trial subscription to Action Alerts PLUS.

  • [By Chris Lange]

    Apache Corp. (NYSE: APA) fourth-quarter results are scheduled for Thursday. The consensus forecast is for $0.22 in EPS on $1.55 billion in revenue. Shares were trading at $38.11. The consensus price target is $50.43. The 52-week range is $35.70 to $56.51.

  • [By Paul Ausick]

    Apache Corp. (NYSE: APA) dropped about 7.3% Thursday to post a new 52-week low of $34.50. Shares closed at $37.20 on Wednesday and the stock’s 52-week high is $55.23. Volume was over 11 million, about three times the daily average of around 3.9 million. The company reported quarterly results this morning, but investors were not impressed.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was Apache Corp. (NYSE: APA) which traded down over 7% at $42.51. The stocks 52-week range is $38.14 to $69.00. Volume was over 14 million versus the daily average of 3.4 million shares.

Top 5 Blue Chip Stocks To Buy Right Now: eHealth Inc.(EHTH)

Advisors’ Opinion:

  • [By Lisa Levin]

    eHealth, Inc. (NASDAQ: EHTH) was down, falling around 32 percent to $9.53. eHealth reported a Q2 net loss of $0.5 million, versus a year-ago net income of $5.8 million. The company also reported weak quarterly revenue.

Top 5 Blue Chip Stocks To Buy Right Now: Bayer Aktiengesellschaft (BAYRY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    You can torture the data many ways, of course, and there were some pharma price increases in the US, but apparently, they were not especially large. What hurt were discounting, especially for Xarelto, a Bayer (OTCPK:BAYRY) oral anticoagulant which JNJ markets in the US; and the diabetes Invokana line.

  • [By Todd Campbell]

    Nektar Therapeutics is working with Bayer AG (NASDAQOTH:BAYRY) on an inhaledversion of Amikacin, an anti-bacterial that if successful in trials could be used alongside standard of care to treat gram-negative pneumonia in intubated and mechanically ventilated patients. If it’s eventually approved in the U.S., Nektar Therapeutics will receive a flat 30% royalty on sales. It’s also working with Bayer on an inhaled powder formulation of Cipro that could be used to treat chronic lung infections in cystic fibrosis patients. Top-line phase 3 results on both drugs should be available this year.

  • [By SEEKINGALPHA.COM]

    The Regeneron press release in November for its Q3 2017 financial and operating results reaffirmed Eylea’s full year 2017 U.S. net product sales growth of approximately 10% over 2016, which could be about $1 billion. From our model, we see the Q4 total revenues for Eylea, excluding sales outside the United States from Regeneron’s collaborative partner Bayer AG (OTCPK:BAYRY), of $1.2 billion, or a 17% increase year-on-year. REGN stock has a forward P/E ratio of 21.83 as of December 8, 2017, while the current trailing P/E is 34.57.

  • [By SEEKINGALPHA.COM]

    This type of spin-off is not uncommon among German companies, as they streamline their portfolios to focus on the where they have more competitive advantages in the long term. For instance, in the recent past, Siemens (OTCPK:SIEGY) has split out Osram (OTC:OSAGY) and Bayer (OTCPK:BAYRY) has performed the spin-off of Covestro (OTCPK:CVXTY), something that Rheinmetall is likely to do in the near future because its auto unit has reached peak margins, and therefore this is the best time to spin-off the business.

  • [By SEEKINGALPHA.COM]

    Rivaroxaban was initially developed by Janssen, a subsidiary of Johnson & Johnson (NYSE:JNJ). It later entered an agreement with Bayer (OTCPK:BAYRY) to jointly complete the development process in 2005.

  • [By ]

    Bayer AG (BAYRY) also rose 4.13% to 97.29 on reports that its mega-merger with Monsanto Co. (MON) would likely be approved by the Department of Justice. The Wall Street Journal reported that the companies have agreed additional asset sales.

Top 5 Blue Chip Stocks To Buy Right Now: Williams-Sonoma Inc.(WSM)

Advisors’ Opinion:

  • [By Steve Symington] Williams-Sonoma(NYSE:WSM)announced better-than-expected fiscal fourth-quarter 2016 results Wednesday after the market closed. But that doesn’t mean the Pottery Barn parent was without its challenges over the key holiday period. Let’s take a closer look at how Williams-Sonoma capped the year, as well as what investors can expect from the company going forward.

    Image source: Williams-Sonoma/Pottery Barn via BusinessWire.

  • [By Peter Graham]

    A long term performance chart shows shares of RH back around their all time highs while the performance of other furniture or home d茅cor retailers likemid capBed Bath & Beyond Inc (NASDAQ: BBBY), mid cap Williams-Sonoma, Inc (NYSE: WSM) and small capPier 1 Imports Inc (NYSE: PIR) have largelydrifted downward or sideways for at least a year:

  • [By Peter Graham]

    A long term performance chart shows shares of small cap Pier 1 Imports and mid cap Bed Bath & Beyond Inc (NASDAQ: BBBY) underperforming while mid capWilliams-Sonoma, Inc (NYSE: WSM)isabove breakeven levels andsmallcap Restoration Hardware Holdings Inc (NYSE: RH)is once again performing well (but with considerable volatility):

  • [By Peter Graham]

    Mid cap home products retailerWilliams-Sonoma, Inc (NYSE: WSM) reported Q2 2017 earnings after the Wednesday market close with results exceeding Wall Street expectations. Net revenues grew 3.7% to $1.202 billion versus $1.159 billion with comparable brand revenue growth of 2.8% on top of 0.6% in Q2 2016:

  • [By Peter Graham]

    A long term performance chart shows mid cap Bed Bath & Beyond in a steady decline since around early 2015 while small capPier 1 Imports Inc (NYSE: PIR)has performed worst,small capRestoration Hardware Holdings Inc (NYSE: RH) is back up amidst volatility andmid capWilliams-Sonoma, Inc (NYSE: WSM)is backto breakeven:

  • [By Peter Graham]

    A long term performance chart shows mid cap Bed Bath & Beyond in a steady decline since early 2015 while and small capPier 1 Imports Inc (NYSE: PIR)has performed worst, mid capRestoration Hardware Holdings Inc (NYSE: RH) is back up andmid capWilliams-Sonoma, Inc (NYSE: WSM)has drifted lower:

Top 5 Blue Chip Stocks To Buy Right Now: Facebook, Inc.(FB)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Among the others in the fray are Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL), with a market cap of $650.77 billion, Microsoft Corporation (NASDAQ: MSFT) ($536.62 million) and Facebook Inc (NASDAQ: FB) ($433.95 million).

  • [By Evan Niu, CFA]

    Censorship is almost always a touchy subject, but it’s also par for the course in certain parts of the world. Just as Facebook (NASDAQ:FB) is now coming to grips with its own power and responsibility over what information people see, it seems that the company is starting to flirt a little bit with censorship.

  • [By Lee Jackson]

    Facebook Inc. (NASDAQ: FB) had another tech industry giant selling stock recently, The Chief Operating Officer Sheryl Sandberg sold a total of 109,000 shares at $117.65 apiece. The total proceeds from her trade was set at $12,824,074. The stock wastrading at $115.o5 on Friday’s close. The 52-week range for the social media conglomerate is $89.37 to $133.50, and the consensus price target is $155.56.